Salignostics

Company Overview

Snapshot

Founded in January 2017 by Omer Deutsch, Guy Krief, Yoav Neumann, Raluca Cohen, and Aaron Palmon, Salignostics is a Health Tech & Life Sciences company with 11–50 employees. The company has secured funding across 3 rounds and recently received a grant from the Bill & Melinda Gates Foundation in June 2026.

Business overview

Salignostics develops rapid, safe, user-friendly, and cost-effective saliva-based diagnostic solutions. Its proprietary technology processes saliva into an analyzable body fluid, enabling non-invasive and painless diagnostics for self-testing, homecare, point-of-care, and laboratory settings. The company's products facilitate easy saliva self-collection, sample preparation, and rapid detection of various analytes and biomarkers, including human proteins, viral proteins, DNA, and RNA. Salignostics operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Test Diagnostics & Screening, addressing the home diagnostics market and broader healthcare needs.

Strategic signal

In June 2026, Salignostics received a grant from the Bill & Melinda Gates Foundation. This funding is intended to accelerate the development of non-invasive diagnostics, signaling a strategic focus on improving access to testing in developing regions and validating the company's technology for global health impact.

Company Intelligence Q&A

What is Salignostics' core product?

Salignostics' core product is its saliva-based diagnostic technology, which processes saliva into an analyzable body fluid for rapid, non-invasive, and cost-effective detection of various analytes and biomarkers. This technology underpins products like Salistick, the first rapid saliva-based pregnancy test.

When did Salignostics launch its saliva-based pregnancy test in Germany?

In December 2025, Salignostics launched the world's first saliva-based pregnancy test in Germany through a distribution partnership with Mertz Pharma Handel GmbH, making it available via Rossmann pharmacy chains.

What strategic partnership did Salignostics form in May 2024?

In May 2024, Salignostics partnered with ARC, the innovation department of Sheba Medical Center, to develop a saliva-based diagnostic tool for oral cavity cancer. This collaboration aims to create the first saliva-based diagnostic for cancer, addressing the need for early detection.

What was a key distribution expansion for Salistick in the UK?

In August 2023, Salistick, the saliva pregnancy test, was launched in Tesco stores across the UK and online, following its initial launch with Superdrug. Abingdon Health plc is the exclusive distributor for Salistick in the UK and Ireland.

Who was appointed as Chief Strategy and Business Development Officer in July 2023?

In July 2023, Hagai Dror, a former senior official at the Israeli Ministry of Health, was appointed as Chief Strategy and Business Development Officer at Salignostics, bringing extensive experience to the company's leadership team.